477 related articles for article (PubMed ID: 15767622)
1. Recommendations for the diagnosis and treatment of the acute porphyrias.
Anderson KE; Bloomer JR; Bonkovsky HL; Kushner JP; Pierach CA; Pimstone NR; Desnick RJ
Ann Intern Med; 2005 Mar; 142(6):439-50. PubMed ID: 15767622
[TBL] [Abstract][Full Text] [Related]
2. Neurovisceral porphyrias: what a hematologist needs to know.
Bonkovsky HL
Hematology Am Soc Hematol Educ Program; 2005; ():24-30. PubMed ID: 16304355
[TBL] [Abstract][Full Text] [Related]
3. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
Wang B; Bonkovsky HL; Lim JK; Balwani M
Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
[TBL] [Abstract][Full Text] [Related]
4. A family with acute intermittent porphyria.
Billoo AG; Lone SW
J Coll Physicians Surg Pak; 2008 May; 18(5):316-8. PubMed ID: 18541093
[TBL] [Abstract][Full Text] [Related]
5. [Porphyrias].
Stölzel U; Stauch T; Doss MO
Internist (Berl); 2010 Dec; 51(12):1525-33; quiz 1534. PubMed ID: 21104216
[TBL] [Abstract][Full Text] [Related]
6. Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.
Marcacci M; Ricci A; Cuoghi C; Marchini S; Pietrangelo A; Ventura P
Orphanet J Rare Dis; 2022 Apr; 17(1):160. PubMed ID: 35392955
[TBL] [Abstract][Full Text] [Related]
7. [Anesthesia in patients with acute porphyria].
Lederer D; Weigand MA; Larmann J
Anaesthesist; 2022 Apr; 71(4):321-330. PubMed ID: 35352131
[TBL] [Abstract][Full Text] [Related]
8. Role of delta-aminolevulinic acid in the symptoms of acute porphyria.
Bissell DM; Lai JC; Meister RK; Blanc PD
Am J Med; 2015 Mar; 128(3):313-7. PubMed ID: 25446301
[TBL] [Abstract][Full Text] [Related]
9. Management of acute and cutaneous porphyrias.
Badminton MN; Elder GH
Int J Clin Pract; 2002 May; 56(4):272-8. PubMed ID: 12074210
[TBL] [Abstract][Full Text] [Related]
10. Portuguese Consensus on Acute Porphyrias: Diagnosis, Treatment, Monitoring and Patient Referral.
Brito Avô L; Pereira L; Oliveira A; Ferreira F; Filipe P; Coelho Rodrigues I; Couto E; Ferreira F; Airosa Pardal A; Morgado P; Moreira S
Acta Med Port; 2023 Nov; 36(11):753-764. PubMed ID: 37924314
[TBL] [Abstract][Full Text] [Related]
11. [Acute intermittent porphyria: Long-term follow up of 35 patients].
Herrero C; Badenas C; Aguilera P; To-Figueras J
Med Clin (Barc); 2015 Oct; 145(8):332-7. PubMed ID: 25194977
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietic and hepatic porphyrias.
Gross U; Hoffmann GF; Doss MO
J Inherit Metab Dis; 2000 Nov; 23(7):641-61. PubMed ID: 11117426
[TBL] [Abstract][Full Text] [Related]
13. RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria.
Sardh E; Harper P
J Intern Med; 2022 May; 291(5):593-610. PubMed ID: 35067977
[TBL] [Abstract][Full Text] [Related]
14. Acute intermittent porphyria.
Herrick AL; McColl KE
Best Pract Res Clin Gastroenterol; 2005 Apr; 19(2):235-49. PubMed ID: 15833690
[TBL] [Abstract][Full Text] [Related]
15. Acute hepatic porphyrias for the neurologist: current concepts and perspectives.
Souza PVS; Badia BML; Farias IB; Gonçalves EA; Pinto WBVR; Oliveira ASB
Arq Neuropsiquiatr; 2021 Jan; 79(1):68-80. PubMed ID: 33656101
[TBL] [Abstract][Full Text] [Related]
16. Hepatic porphyria: A narrative review.
Arora S; Young S; Kodali S; Singal AK
Indian J Gastroenterol; 2016 Nov; 35(6):405-418. PubMed ID: 27796941
[TBL] [Abstract][Full Text] [Related]
17. Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries.
Prabahar MR; Manorajan R; Sathiyakumar D; Soundararajan P; Jayakumar M
Hemodial Int; 2008 Jan; 12(1):34-8. PubMed ID: 18271838
[TBL] [Abstract][Full Text] [Related]
18. Porphyrias.
Kauppinen R
Lancet; 2005 Jan 15-21; 365(9455):241-52. PubMed ID: 15652607
[TBL] [Abstract][Full Text] [Related]
19. Update review of the acute porphyrias.
Stein PE; Badminton MN; Rees DC
Br J Haematol; 2017 Feb; 176(4):527-538. PubMed ID: 27982422
[TBL] [Abstract][Full Text] [Related]
20. RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice.
Yasuda M; Gan L; Chen B; Kadirvel S; Yu C; Phillips JD; New MI; Liebow A; Fitzgerald K; Querbes W; Desnick RJ
Proc Natl Acad Sci U S A; 2014 May; 111(21):7777-82. PubMed ID: 24821812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
